The Boundless Life Sciences Group announced today that Tim O’Sullivan will become the CEO of Boundless AI, a new agency founded by Boundless, and centered on how AI will reinvent the marketing offering.
“A new era of creativity is about to be unleashed,” said Kerry Hilton, Founder and CEO, The Boundless Life Sciences Group. “We will stay centered on ideas that improve outcomes and provide improved value for patients and caregivers.”
O’Sullivan will build AI-enabled services and solutions focused on how to optimize marketing efforts, increase engagement and absorption of a narrative, improve the speed and efficiency of the marketing funnel, and run a continual series of pilots designed to provide a unique edge for Boundless and Next Practices Group Health (NPGH) clients. NPGH is a global health platform designed to unite strategies for clients, embrace and effectively implement new technologies, enable collaboration with new partners, and facilitate fully integrated and innovative advertising, marketing, public affairs, and communications programs. Its three foundational firms are Boundless Life Sciences Group, Bliss Bio Health, and FUSE Health.
“Our most important metric is also the simplest,” said O’Sullivan. “If an AI-driven solution increases value for our clients, we will proceed. If it is hype, we’ll shelve it. We will be methodical and pragmatic in how we innovate, so our solutions align with the needs and the governance requirements in the healthcare industry.”
Boundless AI will combine the current innovation occurring within NPGH via its data science, media, analytics, and AI modeling teams, as well as its clinical trial recruitment and health systems experience.
“Innovation requires having the right ingredients and the expertise to accompany it,” added Bob Pearson, Founder & CEO of Next Practices Group. “The future of healthcare innovation requires equal knowledge of science, software, security, and storytelling to create meaningful products and services.”
O’Sullivan has previously worked as a Principal for Capgemini Invent, leading customer transformation, omnichannel marketing, and digital solutions. Prior to Capgemini, he worked at 21 Grams, a Real Chemistry company, as a VP, Account Director.
